Saturday, April 21, 2018
 
 
 

 
 
THOUSAND OAKS, Calif., April 2, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has approved an expanded indication for XGEVA® (denosumab) for the prevention of skeletal-related events in adults with advanced malignancies involving bone. The indication now covers patients .....   [READ MORE]
BELLINGHAM, Wash., March 13, 2018 /PRNewswire-PRWeb/ -- Fairhaven Health, a leader in natural, science-based women's health care products, has launched IsoFresh Probiotic, the newest addition to the company's award-win.....   [READ MORE]
 
PUNE, India, March 6, 2018 /PRNewswire/ --   [READ MORE]
 
 
MORE NEWS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 





About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines